Objective: This study aims to observe the morphological characteristics of bacterial biofilm on the surface of ureteral stents and analyze distribution characteristics of pathogens on the bacterial biofilm and drug resistance. Methods: Ureteral stents were sampled from 129 patients. A scanning electron microscope was used to observe the morphological characteristics of bacterial biofilms, and the Congo red medium was applied to screen bacterial biofilm strains on the renal pelvis section, ureter section, and bladder section respectively. Urine culture was performed, and the drug sensitive test analysis was carried out for the pathogenic bacteria detected. Results: Bacterial biofilms can be observed on the surface of ureteral stents, and these bacteria are embraced by large amounts of fiber membranes. A total of 107 patients were found to be positive for biofilms with a positive rate of 82.9%. The positive rates of the bladder section, ureter section, renal pelvis section, and urine culture were 85.0, 42.9, 67.3, and 24.3% respectively. Pathogenic bacteria mainly concentrated on Escherichia coli, and the drug resistance rate of the bacterial biofilm strains on the ureteral stent was relatively higher. Conclusion: The bacterial biofilm on the ureteral stent is an important factor that induces catheter-associated urinary tract infections.

Keywords:
Bacterial biofilm, Ureteral stent, Drug resistance, Catheter-associated urinary tract infections
1.
Tenke P, Köves B, Nagy K, Hultgren SJ, Mendling W, Wullt B, Grabe M, Wagenlehner FM, Cek M, Pickard R, Botto H, Naber KG, Bjerklund Johansen TE: Update on biofilm infections in the urinary tract. World J Urol 2012; 30: 51–57.
2.
Zelichenko G, Steinberg D, Lorber G, Friedman M, Zaks B, Lavy E, Hidas G, Landau EH, Gofrit ON, Pode D, Duvdevani M: Prevention of initial biofilm formation on ureteral stents using a sustained releasing varnish containing chlorhexidine: in vitro study. J Endourol 2013; 27: 333–337.
3.
Tehranchi A, Rezaei Y, Khalkhali H, Rezaei M: Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial. Int Braz J Urol 2013; 39: 832–840.
4.
Weber DJ, Sickbert-Bennett EE, Gould CV, Brown VM, Huslage K, Rutala WA: Incidence of catheter-associated and non-catheter-associated urinary tract infections in a healthcare system. Infect Control Hosp Epidemiol 2011; 32: 822–823.
5.
Klevens RM, Edwards JR, Richards CL Jr: Estimating healthcare-associated infections and deaths in US hospitals. Public Health Rep 2007; 122: 160–166.
6.
Gorman SP, Mawhinney WM, Adair CG, Issouckis M: Confocal scanning laser microscopy of CAPD catheter surface microrugosity in relation to recurrent peritonitis. J Med Microbiol 1993; 38: 411–417.
7.
Jones DS, Gorman SP, McCafferty DF: A comparative study of the effects of three non-antibiotic antimicrobial agents on the surface hydrophobicity of certain microorganisms. J Appl Bacteriol 1991; 71: 218–227.
8.
Mawhinney WM, Adair CG, Gorman SP: Factors influencing the adherence of microbial pathogens to CAPD catheters. Pharmacotherapy 1992; 12: 253.
9.
Ozgur BC, Ekici M, Yuceturk CN, Bayrak O: Bacterial colonization of double J stents and bacteriuria frequency. Kaohsiung J Med Sci 2013; 29: 658–661.
10.
Choong S, Whitfield H: Biofilms and their role in infections in urology. BJU Int 2000; 86: 935–941.
11.
Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318–1322.
12.
Denstedt JD, Cadieux PA: Eliminating biofilm from ureteral stents: the holy grail. Curr Opin Urol 2009; 19: 205–210.
13.
Bader MJ, Zilinberg K, Weidlich P, Waidelich R, Püls M, Gratzke C, Stief CG, Stepp H, Sroka R: Encrustation of urologic double pigtail catheters-an ex vivo optical coherence tomography (OCT) study. Lasers Med Sci 2013; 28: 919–924.
14.
Petrova OE, Sauer K: Escaping the biofilm in more than one way: desorption, detachment or dispersion. Curr Opin Microbiol 2016; 30: 67–78.
15.
Schroeder M, Brooks BD, Brooks AE: The complex relationship between virulence and antibiotic resistance. Genes 2017; 8: 39.
16.
Gabi M, Hefermehl L, Lukic D, Zahn R, Vörös J, Eberli D: Electrical microcurrent to prevent conditioning film and bacterial adhesion to urological stents. Urol Res 2011; 39: 81–88.
17.
Lock JY, Wyatt E, Upadhyayula S, Whall A, Nuñez V, Vullev VI, Liu H: Degradation and antibacterial properties of magnesium alloys in artificial urine for potential resorbable ureteral stent applications. J Biomed Mater Res A 2014; 102: 781–792.
18.
Aydin HR, Irkilata L, Aydin M, et al: Incidence of bacterial colonisation after indwelling of double-J ureteral stent. Arch Ital Urol Androl 2016; 87: 291–294.
19.
Ben-Meir D, Golan S, Ehrlich Y, Livne PM: Characteristics and clinical significance of bacterial colonization of ureteral double-J stents in children. J Pediatr Urol 2009; 5: 355–358.
20.
Farsi HM, Mosli HA, Al-Zemaity MF, Bahnassy AA, Alvarez M: Bacteriuria and colonization of double-pigtail ureteral stents: long-term experience with 237 patients. Endourol 1995; 9: 469–472.
21.
Cauda V, Fiori C, Cauda F: Clinical device-related article Ni-Cr-Co alloy ureteral stent: scanning electron microscopy and elemental analysis characterization after long-term indwelling. J Biomed Mater Res 2010; 94: 501–507.
22.
Bonkat G, Rieken M, Müller G, et al: Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle. World J Urol 2013; 31: 541–546.
23.
Kram W, Buchholz N, Hakenberg OW: Ureteral stent encrustation. Pathophysiology. Arch Esp Urol 2016; 69: 485–493.
24.
Stickler DJ, Feneley RC: The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control. Spinal Cord 2010; 48: 784–790.
25.
Tambyah PA, Maki DG: Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med 2000; 160: 678–682.
26.
Klis R, Korczak-Kozakiewicz E, Denys A, Sosnowski M, Rozanski W: Relationship between urinary tract infection and self-retaining double-J catheter colonization. J Endourol 2009; 23: 1015–1019.
27.
Jean SS, Teng LJ, Hsueh PR, Ho SW, Luh KT: Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital. J Antimicrob Chemother 2002; 49: 69–76.
28.
Boll EJ, Struve C, Boisen N, Olesen B, Stahlhut SG, Krogfelt KA: Role of enteroaggregative Escherichia coli virulence factors in uropathogenesis. Infect Immune 2013; 81: 1164–1171.
29.
Zamani H, Salehzadeh A: Biofilm formation in uropathogenic Escherichia coli: association with adhesion factor genes. Turk J Med Sci 2018; 48: 162–167.
30.
Lyczak JB, Cannon CL, Pier GB: Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002; 15: 194–222.
31.
Jackson KD, Starkey M, Kremer S, Parsek MR, Wozniak DJ: Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J Bacteriol 2004; 186: 4466–4475.
32.
Stickler DJ: Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. J Intern Med 2014; 276: 120–129.
33.
Saint S, Chenoweth CE: Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003; 17: 411–432.
34.
Liedl B: Catheter-associated urinary tract infections. Curr Opin Urol 2001; 11: 75–79.
35.
Cirioni O, Ghiselli R, Silvestri C, Minardi D, Gabrielli E, Orlando F, Rimini M, Brescini L, Muzzonigro G, Guerrieri M, Giacometti A: Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection. J Antimicrob Chemother 2011; 66: 1318–1323.
36.
Zhao J, Cao Z, Ren L, Chen S, Zhang B, Liu R, Yang K: A novel ureteral stent material with antibacterial and reducing encrustation properties. Mater Sci Eng C Mater Biol Appl 2016; 68: 221–228.
37.
Elwood CN, Lo J, Chou E, Crowe A, Arsovska O, Adomat H, Miyaoka R, Tomlinson-Guns E, Monga M, Chew BH, Lange D: Understanding urinary conditioning film components on ureteral stents: profiling protein components and evaluating their role in bacterial colonization. Biofouling 2013; 29: 1115–1122.
38.
Rosman BM, Barbosa JA, Passerotti CP, Cendron M, Nguyen HT: Evaluation of a novel gel-based ureteral stent with biofilm-resistant characteristics. Int Urol Nephrol 2014; 46: 1053–1058.
39.
Cirioni O, Silvestri C, Ghiselli R, Kamysz W, Minardi D, Castelli P, Orlando F, Kamysz E, Provinciali M, Muzzonigro G, Guerrieri M, Giacometti A: In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. Infez Med 2013; 21: 287–295.
40.
Gultekinoglu M, Tunc Sarisozen Y, Erdogdu C, Sagiroglu M, Aksoy EA, Oh YJ, Hinterdorfer P, Ulubayram K: Designing of dynamic polyethyleneimine (PEI) brushes on polyurethane (PU) ureteral stents to prevent infections. Acta Biomater 2015; 21: 44–54.
41.
Brotherhood H, Lange D, Chew BH: Advances in ureteral stents. Transl Androl Urol 2014; 3: 314–319.
42.
Maria Manohar C, Doble M: Papain immobilized polyurethane as an ureteral stent material. J Biomed Mater Res 2016; 104: 723–731.
43.
Zumstein V, Betschart P, Albrich WC, et al: Biofilm formation on ureteral stents – Incidence, clinical impact, and prevention. Swiss Med Wkly 2017; 147:w1440.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.